In lung cancer cells, ginsenoside Rg3 inhibits ROS production, leading to NF-κB and HIF-1α-mediated downregulation of PTX3, and inhibits gemcitabine induced MDR of lung cancer cells [638]. This evidence concerns the gene NFKB1 and lung carcinoma.